LOX and carcinoma: In addition, the expression levels of CD41, CD31 (MVD), BCAR1, VEGF, LOX and FAK were positively correlated with the clinical stages in the carcinoma (SCC, MC and CCC) samples (r=0.528, 0.613, 0.575, 0.575, 0.43, 0.571 and 0.589, respectively).